These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6807451)

  • 1. Successful treatment of Cushing's disease using yttrium-90 rods.
    White MC; Doyle FH; Mashiter K; Joplin GF
    Br Med J (Clin Res Ed); 1982 Jul; 285(6337):280-2. PubMed ID: 6807451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Cushing's disease in juveniles with interstitial pituitary irradiation.
    Cassar J; Doyle FH; Mashiter K; Joplin GF
    Clin Endocrinol (Oxf); 1979 Sep; 11(3):313-21. PubMed ID: 509744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long term follow-up of patients with Cushing's disease treated by interstitial irradiation.
    Sandler LM; Richards NT; Carr DH; Mashiter K; Joplin GF
    J Clin Endocrinol Metab; 1987 Sep; 65(3):441-7. PubMed ID: 3114299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Cushing's disease by interstitial pituitary irradiation: short- and long-term follow-up.
    Molinatti GM; Limone P; Porta M
    Panminerva Med; 1995 Mar; 37(1):1-7. PubMed ID: 7478714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The long-term outcome of pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing's disease.
    Estrada J; Boronat M; Mielgo M; Magallón R; Millan I; Díez S; Lucas T; Barceló B
    N Engl J Med; 1997 Jan; 336(3):172-7. PubMed ID: 8988897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance.
    Atkinson AB; Kennedy A; Wiggam MI; McCance DR; Sheridan B
    Clin Endocrinol (Oxf); 2005 Nov; 63(5):549-59. PubMed ID: 16268808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Criteria for surgical therapy of hypothalamo-hypophyseal Cushing's syndrome].
    Ozyol MB; Voigt KH; Herfarth C; Fehm HL; Teller W; Petrykovski Wv; Schmidt K
    Chirurg; 1977 Apr; 48(4):267-70. PubMed ID: 193673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Criteria for the surgical treatment of hypothalamo-hypophyseal-dependent Cushing's syndrome].
    Ozyol MB; Voigt KH; Fehm HL; Schmidt K; Herfarth C
    Langenbecks Arch Chir; 1976; Suppl():87-90. PubMed ID: 1031834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anterior pituitary function after treatment of Cushing's disease with interstitial irradiation.
    Donckier J; Williams G; Burrin JM; Joplin GF
    Acta Clin Belg; 1988; 43(3):185-93. PubMed ID: 3414307
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of Cushing's disease with low dose radiation therapy.
    Ahmed SR; Shalet SM; Beardwell CG; Sutton ML
    Br Med J (Clin Res Ed); 1984 Sep; 289(6446):643-6. PubMed ID: 6089947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
    Mukherjee A; Murray RD; Teasdale GM; Shalet SM
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implantation of the pituitary with yttrium90 in a case of Cushing's syndrome.
    MOLINATTI GM; CAMANNI F; TEDESCHI M
    J Clin Endocrinol Metab; 1959 Sep; 19():1144-50. PubMed ID: 14423367
    [No Abstract]   [Full Text] [Related]  

  • 13. Malignant evolution of an ACTH-producing pituitary tumor treated with intrasellar implantation of 90Y. Case report and review of the literature.
    Papotti M; Limone P; Riva C; Gatti G; Bussolati G
    Appl Pathol; 1984; 2(1):10-21. PubMed ID: 6098287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Multiple recurrence of Cushing's syndrome after bilateral adrenalectomy and pituitary gland surgery. Cure with o,p'-DDD].
    Bigler U; Müller J
    Schweiz Med Wochenschr; 1978 Jan; 108(2):67-72. PubMed ID: 622536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apparently complete restoration of normal daily adrenocorticotropin, cortisol, growth hormone, and prolactin secretory dynamics in adults with Cushing's disease after clinically successful transsphenoidal adenomectomy.
    Veldman RG; Frölich M; Pincus SM; Veldhuis JD; Roelfsema F
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4039-46. PubMed ID: 11095430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pituitary function following megavoltage therapy for Cushing's disease: long term follow up.
    Sharpe GF; Kendall-Taylor P; Prescott RW; Ross WM; Davison C; Watson MJ; Cook DB
    Clin Endocrinol (Oxf); 1985 Feb; 22(2):169-77. PubMed ID: 3921294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and endocrine responses to pituitary radiotherapy in pediatric Cushing's disease: an effective second-line treatment.
    Storr HL; Plowman PN; Carroll PV; François I; Krassas GE; Afshar F; Besser GM; Grossman AB; Savage MO
    J Clin Endocrinol Metab; 2003 Jan; 88(1):34-7. PubMed ID: 12519825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic changes resulting from 90Ytirradiation of the pituitary in a patient with Cushing's syndrome.
    BROOKS RV; McSWINEY RR; MATTINGLY D; PRUNTY FT
    J Endocrinol; 1959 Dec; 19():366-76. PubMed ID: 13804793
    [No Abstract]   [Full Text] [Related]  

  • 19. Relationship of bioassayable and immunoassayable plasma ACTH and cortisol concentrations in normal subjects and in patients with Cushing's disease.
    Krieger DT; Allen W
    J Clin Endocrinol Metab; 1975 Apr; 40(4):675-87. PubMed ID: 165214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cushing's disease. Treatment by pituitary implantation of radioactive gold or yttrium seeds.
    Burke CW; Doyle FH; Joplin GF; Arnot RN; Macerlean DP; Fraser TR
    Q J Med; 1973 Oct; 42(168):693-714. PubMed ID: 4369894
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.